Southeastern Clinical Research Institute

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease2 trials
• Heart failure2 trials
• Obesity2 trials
• Type 2 diabetes2 trials
• Coronary artery disease1 trial
• Peripheral artery disease1 trial
• Stroke1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Bodyport Inc.1 trial

Running trials

• Not yet recruiting

  A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

  NCT07900633· Phase 3· Eli Lilly and Company· Source

  Contact: Matthew Diamond (principal investigator)

• Recruiting

  Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

  NCT07059962· Bodyport Inc.· Source

  Contact: Meredith Prichard

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Heart failure1 recruiting
• Obesity1 recruiting
• Type 2 diabetes1 recruiting